Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component

Concepcion Perez, Rafael Galvez, Silvia Huelbes, Joaquin Insausti, Didier Bouhassira, Silvia Diaz, Javier Rejas, Concepcion Perez, Rafael Galvez, Silvia Huelbes, Joaquin Insausti, Didier Bouhassira, Silvia Diaz, Javier Rejas

Abstract

Background: This study assesses the validity and reliability of the Spanish version of DN4 questionnaire as a tool for differential diagnosis of pain syndromes associated to a neuropathic (NP) or somatic component (non-neuropathic pain, NNP).

Methods: A study was conducted consisting of two phases: cultural adaptation into the Spanish language by means of conceptual equivalence, including forward and backward translations in duplicate and cognitive debriefing, and testing of psychometric properties in patients with NP (peripheral, central and mixed) and NNP. The analysis of psychometric properties included reliability (internal consistency, inter-rater agreement and test-retest reliability) and validity (ROC curve analysis, agreement with the reference diagnosis and determination of sensitivity, specificity, and positive and negative predictive values in different subsamples according to type of NP).

Results: A sample of 164 subjects (99 women, 60.4%; age: 60.4 +/- 16.0 years), 94 (57.3%) with NP (36 with peripheral, 32 with central, and 26 with mixed pain) and 70 with NNP was enrolled. The questionnaire was reliable [Cronbach's alpha coefficient: 0.71, inter-rater agreement coefficient: 0.80 (0.71-0.89), and test-retest intra-class correlation coefficient: 0.95 (0.92-0.97)] and valid for a cut-off value > or = 4 points, which was the best value to discriminate between NP and NNP subjects.

Discussion: This study, representing the first validation of the DN4 questionnaire into another language different than the original, not only supported its high discriminatory value for identification of neuropathic pain, but also provided supplemental psychometric validation (i.e. test-retest reliability, influence of educational level and pain intensity) and showed its validity in mixed pain syndromes.

Figures

Figure 1
Figure 1
Cut-off point in the DN4 questionnaire optimizing the sensitivity and specificity values for discriminating between neuropathic pain and non-neuropathic pain in the overall sample.
Figure 2
Figure 2
Cut-off point in the DN4 questionnaire optimizing the sensitivity and specificity values for discriminating between pure neuropathic pain (excluding patients with mixed pain) and non-neuropathic pain.
Figure 3
Figure 3
Cut-off point in the DN4 questionnaire optimizing the sensitivity and specificity values for discriminating between peripheral neuropathic pain (excluding patients with mixed pain and central neuropathic pain) and non-neuropathic pain.

References

    1. IASP Task Force in Taxonomy . Pain Terms: A Current List with Definitions and Notes on Usage. In: Merksey H, Bogduk N, editor. Classification of chronic pain syndromes and definitions of pain terms. Second. Seattle, Washington: IASP Press; 1994. pp. 206–213.
    1. Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol. 2001;429:1–11. doi: 10.1016/S0014-2999(01)01302-4.
    1. Backonja MM. Defining neuropathic pain. Anesth Analg. 2003;97:785–90. doi: 10.1213/01.ANE.0000062826.70846.8D.
    1. Bennett GJ. Neuropathic pain: a crisis of definition? Anesth Analg. 2003;97:619–20. doi: 10.1213/01.ANE.0000081724.18956.D9.
    1. Karlsten R, Gordth T. How do drugs relieve neurogenic pain? Drugs Aging. 1997;11:398–412.
    1. Browner WS, Newman TB, Cummings SR. Diseño de un nuevo estudio: III. Pruebas diagnósticas. In: Hulley SB, Cummings SR, editor. Diseño de la Investigación Clínica: Un enfoque epidemiológico. . Barcelona: Doyma; 1993. pp. 97–108.
    1. Gálvez R. Concepto, generalidades, etiología e incidencia del Dolor Neuropático. In: Rafael Gálvez, Mateos y cols, editor. Abordaje Actual del Dolor Neuropático Primera Edición. Master Line & Prodigio SL. Madrid; 2003. pp. 12–22.
    1. Gálvez R, Rejas J, Pérez M, Gómez M. Prevalencia del dolor neuropático en España: implicaciones clínicas, laborales y asistenciales. Med Clin (Barc) 2005;125:221–9. doi: 10.1157/13077380.
    1. Torrance N, Smith BH, Bennett MI, Lee AJ. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281–9. doi: 10.1016/j.jpain.2005.11.008.
    1. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with or without neuropathic characteristics in the general population. 2007.
    1. Hansson P. Difficulties in stratifying neuropathic pain by mechanisms. Eur J Pain. 2003;7:353–7. doi: 10.1016/S1090-3801(03)00051-X.
    1. Cruccu G, Anand P, Attal N, García-Larrea L, Haanpää M, Jørum E, Serra J, Jensen TS. EFNS guidelines on Neuropathic pain assessment. Eur J Neurol. 2004;11:153–162. doi: 10.1111/j.1468-1331.2004.00791.x.
    1. Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–157. doi: 10.1016/S0304-3959(00)00482-6.
    1. Krause SJ, Backonja M. Development of a neuropathic pain questionnaire. Clin J Pain. 2003;19:306–14. doi: 10.1097/00002508-200309000-00004.
    1. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lantéri-Minet L, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new Neuropathic pain diagnostic questionnaire (DN4) Pain. 2005;114:29–36. doi: 10.1016/j.pain.2004.12.010.
    1. Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin. 2006;22:1555–65. doi: 10.1185/030079906X115702.
    1. Freynhagen R, Tolle T, Stemmler E, Gockel U, Stevens M, Maier C. Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT) Curr Med Res Opin. 2006;22:529–37. doi: 10.1185/030079906X89874.
    1. Pérez C, Gálvez R, Insausti J, Bennett M, Ruiz M, Rejas J, y el grupo para el estudio de la validación al español de la escala LANSS Adaptación lingüística y validación al español de la escala LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) para el diagnóstico diferencial del dolor neuropático. Med Clin (Barc) 2006;127:485–91. doi: 10.1157/13093266.
    1. Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tolle TR, Wittchen HU, Jensen TS. Using screening tools to identify neuropathic pain. Pain. 2007;127:199–203. doi: 10.1016/j.pain.2006.10.034.
    1. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;46:1417–32. doi: 10.1016/0895-4356(93)90142-N.
    1. Nunnally JC, Bernstein IJ. Teoría Psicométrica. 3. México: McGraw-Hill; 1995.
    1. Fayers PM, Machin D. Quality of Life: Assessment, analysis and interpretation. West Sussex, UK: John Wiley & Sons Ltd; 2000.
    1. Casas J, Repullo JR, Pereira J. Medidas de calidad de vida relacionada con la salud. Conceptos básicos, construcción y adaptación cultural. Med Clin (Barc) 2001;116:798–796.
    1. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N, for the European Regulatory Issues on Quality of Life Assessment Group Patient-reported outcomes: the example of health-related quality of life – A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal. 2002;36:209–238.
    1. Streiner DL, Norman GR. A practical guide to their development and use. Oxford: Oxford University Press; 1989. Health measurement scales.
    1. Melzack R. The short-form McGill Pain Questionnaire SF-MPQ. Pain. 1987;30:191–7. doi: 10.1016/0304-3959(87)91074-8.
    1. Taube A. Sensitivity, specificity and predictive values: a graphical approach. Stat Med. 1986;5:585–91. doi: 10.1002/sim.4780050606.
    1. Wall PD. Neuropathic pain and injured nerve: central mechanisms. Br Med Bull. 1991;47:631–643.
    1. Bouhassira D, Attal N. Novel strategies for Neuropathic pain. In: Villanueva L, Dickenson T, Ollat H, editor. The pain system in normal and pathological states: a primer for clinicians. IASP press, Seattle; 2004. pp. 299–309.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する